These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 20101714)

  • 21. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal tau-containing filaments in neurodegenerative diseases.
    Crowther RA; Goedert M
    J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau and Alzheimer's disease: Past, present and future.
    Iqbal K
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):116-121. PubMed ID: 38126608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation.
    Hasegawa M; Crowther RA; Jakes R; Goedert M
    J Biol Chem; 1997 Dec; 272(52):33118-24. PubMed ID: 9407097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.
    Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC
    FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.
    Arnaud LT; Myeku N; Figueiredo-Pereira ME
    J Neurochem; 2009 Jul; 110(1):328-42. PubMed ID: 19457109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological-like assembly of tau induced by a paired helical filament core expressed at the plasma membrane.
    Campos-Peña V; Tapia-Ramírez J; Sánchez-Torres C; Meraz-Rios MA
    J Alzheimers Dis; 2009; 18(4):919-33. PubMed ID: 19749435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
    Delacourte A
    Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.
    Qureshi HY; Li T; MacDonald R; Cho CM; Leclerc N; Paudel HK
    Biochemistry; 2013 Sep; 52(37):6445-55. PubMed ID: 23962087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
    Trojanowski JQ; Lee VM
    FASEB J; 1995 Dec; 9(15):1570-6. PubMed ID: 8529836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
    Mold MJ; O'Farrell A; Morris B; Exley C
    J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
    Bancher C; Brunner C; Lassmann H; Budka H; Jellinger K; Wiche G; Seitelberger F; Grundke-Iqbal I; Iqbal K; Wisniewski HM
    Brain Res; 1989 Jan; 477(1-2):90-9. PubMed ID: 2495152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Trends Neurosci; 1993 Nov; 16(11):460-5. PubMed ID: 7507619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.